Showing results (61-70 of 158) with videos related to

Sort By:
Pageof 16
Anti-Cancer Drugs|April 7, 2012
Combination of docetaxel and cetuximab for penile cancer: a case report and literature reviewPasquale Rescigno, Elide Matano, Lucia Raimondo, et al.
Oncology and Therapy|November 13, 2024
Study on the Impact of Hormone Therapy for Prostate Cancer on the Quality of Life and the Psycho-Relational Sphere of Patients: ProQoLFrancesca Cappuccio, Carlo Buonerba, Luca Scafuri, et al.
Medicine|December 26, 2015
Third-Line Chemotherapy for Metastatic Urothelial Cancer: A Retrospective Observational StudyGiuseppe Di Lorenzo, Carlo Buonerba, Teresa Bellelli, et al.
Medicine|January 15, 2016
Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate CancerGiuseppe Di Lorenzo, Sergio Bracarda, Donatello Gasparro, et al.
Metabolites|February 25, 2022
A Metabolomics-Based Screening Proposal for Colorectal CancerJacopo Troisi, Maria Tafuro, Martina Lombardi, et al.
Cancers|December 9, 2020
Clinical and Pathological Characteristics of Metastatic Renal Cell Carcinoma Patients Needing a Second-Line Therapy: A Systematic ReviewNicola Longo, Marco Capece, Giuseppe Celentano, et al.
Anti-Cancer Drugs|May 23, 2013
Tumor-to-tumor metastasis: breast cancer metastatic to thymic epithelial tumorRoberto Moretto, Chiara A Cella, Lucia Raimondo, et al.
Future Science OA|April 5, 2021
Seroprevalence of SARS-CoV-2-specific antibodies in the town of Ariano Irpino (Avellino, Campania, Italy): a population-based studyPellegrino Cerino, Annachiara Coppola, Palmiero Volzone, et al.
Expert Opinion on Therapeutic Targets|March 23, 2013
EGFR mutational status in penile cancerGiuseppe Di Lorenzo, Carlo Buonerba, Gabriella Gaudioso, et al.
Expert Review of Molecular Diagnostics|April 9, 2019
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an updateGiuseppe Lucarelli, Davide Loizzo, Matteo Ferro, et al.
Pageof 16